AAC17_PaulMaffuidBlog

Translating tumor antigens into a fully human antibody (HuMab-5B1) as a platform to diagnose and tread pancreatic cancer

In Americas, Antibodies by Karina KusovaLeave a Comment

Dr. Paul Maffuid of MabVax Therapeutics joined us for Americas Antibody Congress 2016 to discuss ‘translating tumor antigens into a fully human antibody as a platform to diagnose and treat pancreatic cancer ‘.

In this presentation, learn about the evolution of MabVax HuMab Platform technology.

Download this presentation to understand more about:

  • HuMab Discovery Platform
  • MabVax’s rich pipeline of potential mAb products
  • MabVax program progress in 2016

and much more!

Get your copy here!

If you’re interested in learning more about how antibodies can be used to treat and cancers and other diseases , join us at Americas Antibody Congress 2017, held May 23-24 in San Deigo, CA. This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA.

Learn more about Americas Antibody Congress

 

Leave a Comment

Current ye@r *